Saturday, July 26, 2008

Update on Kanzius cancer research

The Erie Times News (goerie.com) noted the following of research planning on the Kanzius effort:

Steven Curley, M.D., visited Erie on Wednesday (23 July 08) and toured the Regional Cancer Center, Hamot Medical Center and Saint Vincent Health Center.

The principal investigator for Kanzius’ cancer-killing device at M.D. Anderson Cancer Center in Houston asked detailed questions about the types of research done at each institution, and whether they could handle Phase II clinical trials.

Curley digested the information, and by evening he announced that Erie would host human trials, if the federal government approves them.


Curley was quoted: Things are going at a faster pace than I ever expected, but we are still two years away from human trials.

GoErie separately noted:

The U.S. Food and Drug Administration must OK the trials, for what would be Phase II of the research into John Kanzius' invention. The agency's approval will depend on test results on large animals and then on experiments on small groups of people. Those small experiments, Phase I of human trials, will be at M.D. Anderson Cancer Center in Houston, where Curley is principal investigator of the radio-frequency generator invented by Kanzius.

"We have to make sure the treatment doesn't hurt anyone," Curley said. "We will go through all the appropriate steps. It will take about two years."

The research outcomes are out of our hands. But we can help finger the money to drive that research.

0 Comments:

Post a Comment

<< Home